No IPO Filing by 8th Qike Health Investment Forum – Event Held in 2017

Date: March 28–30, 2017

Venue: Pudong Shangri-La, Shanghai – China

Conference Agenda and Event Schedule

Day 1 of the Conference: Tuesday, March 28, 2017

12:30 pm – 5:30 pm        Pre-Conference Registration & Entrepreneur Training Camp

Pre-Conference Entrepreneur Training Camp

Training Camp Chair:                Wu Hui, Chief Operating Officer, Zai Lab

Huang Jia, Partner, Wilson Sonsini Goodrich & Rosati

Pang Junyong, General Manager, Suzhou Industrial Park Bio-Industry Development Co., Ltd.

Liu Yuwen, Founding Partner, Mint Angel Fund

1:00 pm – 2:00 pm            How to Raise Capital for a Startup

Host:Liu Yuwen, Founding Partner, Bohe Angel Fund

Xing Fei, Partner, Yucheng Capital

DiMai Biotech(Invited)

Ankeji(Invited)

2:00 pm – 3:00 pm          Leading Clinical R&D in China and Globally

Host:Zhao Yachao, Executive Director, Bioveda

Arthur Zheng, CEO, Pulnovo

Riboquark (Invited)

3:00 pm – 3:15 pmSocial Tea Break

3:15 pm – 4:15 pm          Exploring Creative Cross-Border Collaborations

Host:Huang Jia, Partner, Wilson Sonsini Goodrich & Rosati

Hengrui Medicine

Qilu Pharmaceutical(Invited)

Zai Lab(Invited)

Sanpower Group(Invited)

4:15 pm – 5:15 pm          Seeking Capital Exit Strategies

Moderator:Zhu Jie, Partner, Wilson Sonsini Goodrich & Rosati

Fu Yong, CEO, Yashikang

 5:15 pm – 5:30 pm           Q&A Session and Closing Remarks of the Training Camp

  5:30 pm – 7:00 pm          WSGR & BayHelix Cocktail Reception @Binjiang No. 1

Day 2 of the Conference: Wednesday, March 29, 2017

7:15 am – 8:00 am           Conference Registration and Check-in

8:00 am – 8:10 am           Opening Address

                                 Li Yiping, Co-Founder and CEO, JW Therapeutics

8:10 am – 8:40 am          Keynote Speech 1: New Policies Introduced to Incentivize Pharmaceutical Innovation

                                 Song Ruilin, Executive President, China Pharmaceutical Innovation Promotion Association(Invited)

8:40 am – 9:10 am           Keynote Speech 2: Promoting Innovation Through Robust Regulatory Pathways

                                 Leaders of the China Food and Drug Administration(Invited)

9:10 am –9:40 am            Keynote Speech 3: What Are the Drivers of China’s Healthcare Market?

                                 Zhou Gaobo, Director Partner, McKinsey

Sub-Forum 1: Pharmaceuticals and Biotechnology

Chair of the Subcommittee:Lu Hongbo, Partner, Lilly Asia Ventures

Billion-Dollar Valuation Innovative Company

9:40 am – 10:25 am          Company Presentation

Liang Heng, Chief Financial Officer and Chief Strategy Officer, BeiGene

Beta Pharma(Invited)

Advancing Toward First-in-Class Innovative Drugs

10:25 am – 10:40 am       Corporate Presentation

Yang Dajun, CEO, Ascentage Pharma

10:40 am – 11:20 am       Group Discussion

Lu Xianping, President and Chief Scientific Officer, Chipscreen Biosciences; Chen Li, General Manager, Hua Medicine; Wu Zheng, Chief Executive Officer, Akebia Therapeutics; Wu Jinzi, Chairman and President, Ascletis Pharma

Trending Topics: Oncology Immunotherapy I.O.

11:20 am – 11:35 am       Corporate Presentation

Wenru Song, Co-Founder, Kira Therapeutics

11:35 am – 12:15 pm       Group Discussion

Host:Wenru Song, Co-founder, Kira Therapeutics

Ying Geming, Professor of Immunotherapy, Stanford University / Managing Partner, Vivo Capital

Lei Zheng, Associate Professor, Oncology and Surgery, Johns Hopkins University School of Medicine

*I.O. Biopharmaceuticals

*I.O. Cell Therapy Company

12:15 pm – 1:15 pm          Social Lunch

  1:15pm – 2:15 pm           Group Discussion: Completion of Cross-Border Transactions

Host:Lu Hongbo, Partner, Lilly Asia Ventures

Li Ji, Executive Vice President and Head of Global Business Development, BeiGene

Xue Qun, Chief Executive Officer, Canaan Healthcare

Andrew Chen, Partner, Ernst & Young

Zai Lab(Invited)

Sub-session 2: Emerging Innovative Companies

Chair of the Sub-branch:Li Yiping, Co-Founder and CEO, JW Therapeutics

Outstanding Biopharmaceutical Companies

2:15 am – 2:30 am             Popular Company Presentations

Yu Dechao, Chairman and President, Innovent Biologics(Invited)

2:30 pm – 3:15 pm          Group Discussion

Host:Li Wei, Founding Partner, Yucheng Capital

Qian Xueming, Chairman and Chief Executive Officer, Mabos Biologics

Liu Shigao, Chief Executive Officer, Henlius Biotech(Invited)

Zhou Xinhua, Chief Executive Officer, Genor Biopharma(Invited)

Emerging Innovative Companies

3:15 pm – 3:30 pm             Corporate Presentation

Xu Yinglin, Chairman, Chief Executive Officer and President, Xunuo Pharma

3:30 pm – 4:10 pm          Group Discussion

Jiang Ningjun, CEO, CStone Pharmaceuticals; Wu Chenbing, CEO, EMBiotech

Xue Mingyan, Chief Executive Officer, Hummingbird Biotechnology

Xu Ting, Chairman and Chief Executive Officer, Alphamab Oncology

Session 3: Medical Services

Chair of the Sub-Committee:Chen Lishi, Co-founder and Director, Deda Medical

4:10 pm- 6:00 pm            Group Discussion: Opportunities and Challenges in China's Healthcare Services

Host: 

Lin Rui, Partner, F-Prime Capital

Liang Yingyu, Managing Partner, Qiming Venture Partners

Speakers:

Zhang Wenming, CEO, Deda Medical; Zhang Qiang, Founder, Dr. Zhang Qiang Doctor Group

Mei Jingping, Vice President and General Manager of the Strategic Planning Department, Fosun Pharma

Bi Ye, Founder, Aidin Fertility & Assisted Reproduction

Yao Qiuwu, President, Startalk; Lu Sijia, Chief Technology Officer, Yikon Genomics

6:00 pm – 6:05 pm          Closing Remarks on the First Day of the Conference

Lu Hongbo, Partner, Lilly Asia Ventures

6:05 pm – 6:35 pm            Cocktail Reception

6:35 pm – 8:30 pm          Social Dinner& Qike Award Ceremony

Day 3 of the Conference: Thursday, March 30, 2017

Subsession 4:Medical Technology (Devices, Equipment& Diagnosis)

(Simultaneously held: Sub-session A)

Chair of the Sub-Committee:Yu Chengming, Managing Partner, Vivo Capital

9:00 am –9:30 am            Keynote Speech on Medical Technology

Cheng Lifei, Vice President, Strategic Investment and Business Development, Medtronic

9:30 am – 9:45 am           Global Challenges in Medical Technology: Is It an Opportunity for China?

Yu Chengming, Managing Partner, Wu Capital

9:45 am – 10:45 am         Medical Technologies Under Development in China: A Competitor’s Perspective

Host:Zhang Jiajie, Managing Director, WuXi Capital

John Barr, CEO, Surgical Specialties

Xu Xu, Chief Executive Officer, Demet Medical Technology

Victor Chao, CEO, Golden Stapler

Alex Gu, President of Minimally Invasive Technologies, Medtronic

10:45 am – 11:45 am       Group Discussion: The Future of China's In Vitro Diagnostics Industry

Host:Fan Jianbing, Chairman and Chief Executive Officer, Genetron Health

Kehua Bioengineering(Invited)

Dian Diagnostics(Invited)

Autobio Diagnostics(Invited)

Sansure Biotech(Invited)

Aopu Biotech(Invited)

12:30 pm – 1:30 pm        Social Tea Break

Subsession 5: CROs/Overseas Companies

(Concurrent Session B)

The Renaissance of Innovative Services

 8:30 am – 9:00 am            Corporate Presentation

Yang Qing, Executive Vice President and Chief Operating Officer, WuXi AppTec

9:00 am – 9:40 am            Group Discussion

                                  Host:Yang Qing, Executive Vice President and Chief Operating Officer, WuXi AppTec

Lou Bailiang, Chairman and Chief Executive Officer, Pharmaron(Invited)

*CRO Company

Biopharmaceuticals CRO 

9:40 pm – 9:55 am             Corporate Presentation

*Coming Soon

9:55 am – 10:35 am           Group Discussion:

Qiao Shirui, CEO, Xikang Bio

Wang Shaoxiong, President, Bowei Bio

United States& European Biotechnology Companies

10:35 am – 12:30 pm         Corporate Presentation

This segment will feature 6–8 leading biotechnology companies from Europe and the United States.

Attending companies willTo be announced within one week.

12:30 pm – 1:30pm            Social Lunch

1:30 pm – 3:00pm              Group Discussion:Differences in Venture Capital/Private Equity Financing Valuation Between China and the United States: Arbitrage Opportunities

Or sustainable?

Host:Kong Fanjian, Managing Partner, WuXi Capital

Hu Zhengguo, Chief Financial Officer and Chief Investment Officer, WuXi AppTec

Lin Rui, Partner, STI Capital

UBS SDIC Fund Management

Lu Hongbo, Partner, Lilly Asia Ventures

Sub-Forum 6:Healthcare Information Technology

Host:Cao Yibo, Managing Director, Vivo Capital

3:00 pm – 3:05 pm            BranchOpening Remarks

Yibo Cao, Managing Director, Wu Capital

3:05 pm – 3:30 pm            Mobile Healthcare: Driving the Future

Chen Wei, Managing Director, L.E.K. Consulting

3:30 pm – 5:00 pm           Company Presentation

Zhang Chunyi, General Manager, Viwo Software; Li Fan, Vice President, WeDoctor Group

Ma Xuguang, CEO, Spai Network

Wang Xingwei, Chairman, Winning Health International

Zhang Tianze, CEO, LinkDoc Technology

Dai Fengxiang, Chief Financial Officer, HealthWatch

5:00 pm – 5:55 pm          Group Discussion: How Far from Profitability?

Li Fan, Vice President, WeDoctor Group

Wang Xingwei, Chairman, Winhealth International

Liu Di, CEO, Gengmei APP; Ma Xuguang, CEO, Spai Network

Chen Qirui, Chief Executive Officer, DXY

5:55 pm – 6:00 pm           Closing Address of the Conference

Chen Lishi, Co-founder and Director, Deda Medical